MyAverix Finance
HK · Healthcare
Medtide Inc (3880)
Biotechnology
Medtide Inc (3880) is listed on HK in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported market cap is $3.11B, P/E ratio is 11.65, net margin is 38.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 3880
Medtide Inc (3880) — FAQ
What is Medtide Inc's market cap?
Medtide Inc (3880) has a reported market cap of $3.11B (data as of 2026-05-21).
What is 3880's P/E ratio?
The price-to-earnings (P/E) ratio for Medtide Inc (3880) is 11.65 (data as of 2026-05-21).
Does Medtide Inc pay a dividend?
Dividend yield is not available in the current snapshot for Medtide Inc (3880). Check the MyAverix Finance app for the latest dividend data.
What sector is Medtide Inc in?
Medtide Inc (3880) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 3880 listed on?
3880 is listed on HK.
What is Medtide Inc's net margin?
Medtide Inc (3880) reports a net margin of 38.1% (data as of 2026-05-21).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.